When quant billionaire David Shaw trades, the world listens. One of the most successful hedge funds of all time, Shaw has now made …
In a multi-billion dollar industry fighting for alpha, Laurion Capital’s Benjamin Smith is betting on these two healthcare stocks for success. But while …
Qudian Inc. (NYSE:QD) share price continued to fall Wednesday after the People’s Bank of China (PBOC) forbade the licensing of new micro-lending practices …
Cytokinetics, Incorporated (NASDAQ:CYTK) shareholders were met with a rude awakening when the firm’s lead ALS asset failed to meet the primary endpoint in …
Celsion Corporation (NASDAQ:CLSN) investor sentiment is getting stoked today on back of new bullish attention from Oppenheimer analyst Hartaj Singh. Even though this …
How does Hedge fund guru Dmitry Balyasny’s choice to invest new stakes in Teva Pharmaceutical (NYSE:TEVA) and Synergy Pharmaceuticals (NASDAQ:SGYP) while bumping up …
Valeant Pharmaceuticals (NYSE:VRX) aced its third quarter, but while many on Wall Street were thrilled to see the biotech giant take a stride …
xG Technology Inc (NASDAQ:XGTI) did not put its best foot forward during a third quarter that saw the company meaningfully underclass a bullish …
Can Teva Pharmaceutical (NYSE:TEVA) recover after such a third quarter earnings fall? Mizuho analyst Irina Rivkind Koffler is left asking questions of whether …
Following a third quarter print and clinical update from Aurinia Pharmaceuticals (NASDAQ:AUPH) on its pivotal study in lupus nephritis (LN), Canaccord analyst Neil …
